CANCER CELL 润色咨询

CANCER CELL

出版年份：2002 年文章数：1104 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2016-08-19 ms2466276523160074

    要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。

    3

    展开3条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2022-10-29 susu2019

    偏重的研究方向：肿瘤学;肿瘤
    经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2022-06-02 cindichaw

    18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2021-12-29 MS54455111222

    文章题目有没有撰写模板？

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2021-12-29 桑晒麦拉

    撰写文章题目有没有技巧？

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2021-08-20 132Luux9886

    请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2021-08-16 张晓梅-Xiaomei Zhang

    这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2021-07-15 cindichaw

    参与发了一篇，工作量巨大

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2021-04-14 darktempler

    南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=833222, encodeId=c5198332220d, content=要求比较严，英国人还是比较严谨，1270磅版面费，较贵，下次投个汇率低的国家。 严格按照编辑意见及审稿人意见修改文章，应该较快，自己补充实验较慢，导致投稿时间较慢，历时10个月，自己浪费了3-5月，大修补充实验2次，小修5次。 希望帮到大家。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=248, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Fri Aug 19 12:01:15 CST 2016, time=2016-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2097331, encodeId=f648209e331a9, content=偏重的研究方向：肿瘤学;肿瘤<br>经验分享：集团队重点力量，耗时三年，肿瘤免疫领域，终于发表一篇该期刊。以往都是秒拒，难度还是相当大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=susu2019, createdTime=Sat Oct 29 19:21:16 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224059, encodeId=8d12122405991, content=18年投过一个被拒，20年打酱油发了一个。最近进入产出低潮。手头只有一个工作想冲击一下，可是疫情影响，很多事情耽误。希望下半年能做完投出去。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=130, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jun 02 15:13:54 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091494, encodeId=38681091494e3, content=文章题目有没有撰写模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1091493, encodeId=29a51091493fd, content=撰写文章题目有没有技巧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009794, encodeId=2f231009e9412, content=请问这个提交之后，一般多久就知道要不要送审，还是直接拒掉, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=166, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=b9562152670, createdName=132Luux9886, createdTime=Fri Aug 20 18:51:50 CST 2021, time=2021-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008315, encodeId=b473100831594, content=这期刊是越来越难投了，更加注重临床了，需要大规模的临床数据，意味着小实验室更加不可能发这个期刊了，需要强大的资源后盾，不是大佬很难拿到这么多资源, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=170, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Mon Aug 16 13:31:28 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=999609, encodeId=411199960921, content=参与发了一篇，工作量巨大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4fed1686029, createdName=cindichaw, createdTime=Thu Jul 15 00:06:29 CST 2021, time=2021-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=957032, encodeId=c03195e03209, content=南京鼓楼医院孙倍成教授今年联合国外学者发了一篇关于胰腺癌的文章，他是搞肝移植的啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKbUQVcNicMmoEngbhNsjHtgPVly9ibpH1ngtTSp4EjBLr38AKWnRaGSJRVPTfjNL7rlfd969jibvZaw/132, createdBy=793b1668391, createdName=darktempler, createdTime=Wed Apr 14 19:50:27 CST 2021, time=2021-04-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558726, encodeId=597c558e268d, content=CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCB<span class="quote">sunliang 2018-06-30 发表::<br>啥时候也来一篇呢.好杂志.不容错过</span>, beContent=sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过, objectType=tool_impact_factor, channel=null, level=null, likeNumber=546, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Sun Jul 01 18:05:00 CST 2018, time=2018-07-01, status=1, ipAttribution=)]
    2018-07-01 bigapple001

    CNS子刊 生物医学类里面 最难的就是nature medicine和cancer cell 需要工作量 而不是idea好就能支撑的 审稿也很严格 可以见到很多文章从received到accepted经历了两年多 个人不建议投他家 如果可以 还不如先试试NCBsunliang 2018-06-30 发表::
    啥时候也来一篇呢.好杂志.不容错过

    sunliang 2018-06-30 发表:: 啥时候也来一篇呢.好杂志.不容错过

    1

    展开1条回复
共42条页码: 1/5页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分